[{"Assets_0_FY_USD":25434800000.0,"EarningsPerShareBasic_4_FY_USD":76.4,"EarningsPerShareDiluted_4_FY_USD":71.97,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":7081300000.0,"NetIncomeLoss_4_FY_USD":8075300000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":16071700000.0,"StockholdersEquity_0_FY_USD":18768800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":112200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":105700000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20220207"}]